Skip to content
PeptideRank

Provider review

No BS RX cost: $249/mo tirzepatide

Leads with the walk-away price, then excludes the medication from it.

Six programs, each leading with its month-to-month rate and its three prepay totals. Its own subscription terms then say pharmacy and provider fees are not included in that figure.

Verified September 2026

Reviewed by Marcus Webb

Transparency scorecard

2 of 4 disclosed openly

What No BS RX discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Disclosed

Names its compounding pharmacy and states a federal regulatory category (503A/503B), sourced to its own site.

State coverage published

Not disclosed

Publishes no state coverage list — availability is something you learn during signup.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Not disclosed

The advertised price requires a prepay, auto-refill, or other commitment we found and named.

This review's stake, stated plainlysome of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

At a glance

Visit No BS RX

Pharmacy

503A pharmacy

Labs

Not mentioned as a requirement, a cost or a cadence.

States

Not published

On this page

What it actually costs

What this price covers

Medication

Included

Provider visits

Not confirmed

Shipping

Not confirmed

Lab work

Not confirmed

Coaching

Not confirmed

The catch — Not in the ladder, which is straight. It is in the definition. Its subscription terms state that the fee covers its administrative and technology platform, and then list what that does not include: provider consultation fees, medication costs, dispensing fees and shipping charges, all "determined by and payable to independent, licensed pharmacies" and "not included in the NoBsRx platform subscription". Nothing on the pricing page says the published figure is only part of what you pay.

See plans at No BS RX

Prices read from No BS RX's own site · September 2026

What they advertise

"Programs starting at $140/month" above a page headed "Transparent GLP-1 pricing. No hidden games. Every program. Every price. Before you start."

What you actually pay

$179 a month for injectable semaglutide, $249 for injectable tirzepatide and $199 for the oral, each bought one month at a time. Prepay totals sit beside them: $499, $999 and $1,899 for semaglutide across 12, 24 and 52 weeks; $649, $1,289 and $2,599 for tirzepatide. Three low-dose programs run at $140, $140 and $179.

Money you will meet later

  • Its terms name provider consultation fees, medication and dispensing fees, shipping, and clinical-platform fees as potentially separate charges.
  • Platform fees are non-refundable once a clinical review has started, whatever that review concludes.
  • Being found ineligible for a prescription does not automatically entitle you to a refund.
  • Subscription fees for a billing period already begun are not refunded on cancellation.

The bottom line

No BS RX sells compounded semaglutide at $179 a month, compounded tirzepatide at $249 and an oral semaglutide at $199, with three low-dose programs from $140, and its pricing page does the thing this site spends most of its time asking for: the month-to-month rate comes first and largest on every card, with the 12-, 24- and 52-week totals beside it and no intro rate anywhere. It states 503A on every card, and it is candid that treatment is not guaranteed. The problem is what its own contract says those figures buy. Read the subscription terms and the published price is a platform fee, with the medication, the dispensing and the clinician's time listed as separate charges owed to someone else.

No BS RX appears on our tirzepatide provider ranking, our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You want month-to-month pricing published first rather than a prepay figure dressed as a monthly rate.
  • You want a flat price regardless of dose — every card says the price does not change as the dose climbs.
  • You want a low-dose option priced openly: $140 a month for injectable semaglutide or tirzepatide.

Look elsewhere if

  • You want the published number to be the whole number. Its terms list pharmacy, dispensing, shipping and clinician fees as separate from it.
  • You want to cancel from your account. Cancellation and pausing are both email-only.
  • You want to know whether it operates in your state before you start — it will not say.

What No BS RX offers

Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.

Who fills your prescription

503A pharmacy

No BS RX names the pharmacy that fills your prescription.

What its own site says

Category stated, pharmacy withheld. Its FAQ answers "Is NoBsRx a pharmacy?" with "No. Prescriptions are fulfilled through state-licensed 503A compounding pharmacies using pharmaceutical-grade APIs", and all six pricing cards repeat a "503A pharmacy fulfillment" line. Which pharmacy is never said: its own fulfillment disclosure describes them only as "independent, licensed third-party pharmacies" whose operations, dispensing decisions and shipping timelines it does not control.

What's the difference between 503A and 503B?

A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.

Where you can get it

Not published

Not published, and said so rather than left blank — which is the more honest of the two ways to not answer. Its disclosures state that its programs "are not available in all states" and that it "does not guarantee availability in any particular state", directing you to check during intake. No list, count or exclusion appears.

The honest cons

The part they would rather you skipped

A company called No BS RX built its whole pitch on the price being the price — "No hidden fees", "Know the cost before you start", "No fake intro rates, no dose-based surprises", a homepage section listing hidden pricing and bait-and-switch offers as the industry problems it exists to fix — and then wrote a subscription agreement that takes the medication out of the figure. Its terms describe what a subscription buys as access to its platform, the routing of your intake to a clinician, administrative support and educational content. What a subscription does not include, in its own words, is clinical services and medication fulfillment. The fee section is more specific: provider consultation fees "may or may not be included in your program", and medication costs, dispensing fees and shipping charges "are determined by and payable to independent, licensed pharmacies" and "are not included in the NoBsRx platform subscription". Nowhere on the pricing page — the one headed "Every program. Every price. Before you start." — does any of that appear. Two smaller things sit beneath it. Being turned down does not get your money back: platform fees are non-refundable once a clinical review has begun "regardless of the outcome of that review", and its refund policy states plainly that being found ineligible "does not automatically entitle you to a refund". And cancellation is by email only, handled by its support team, with no self-service option in the account.

  • Its subscription terms exclude medication, dispensing, shipping and possibly the consultation from the published price — see this review's knock.
  • Platform fees are non-refundable once a clinical review starts, and being found ineligible does not automatically earn a refund.
  • Canceling and pausing are both email-only; neither is available in the account.
  • No pharmacy is named, though 503A is stated on every card.
  • No state list is published, and it states outright that availability is not guaranteed anywhere.
  • Its low-dose oral semaglutide is $179 a month with a 12-week price of $409 — the same 12-week figure carried by two $140-a-month programs, so three products at two monthly rates share one quarterly price.
  • Its sleep program advertises being "covered by most insurance" with a typical copay, on a site that otherwise takes no insurance.

None of this is unique to No BS RX — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.

Ready to get started?

Prices and plans in this category change often — check No BS RX's current pricing before you decide. Ours was read from their own site in September 2026.

See No BS RX pricing

Facts on this page reflect No BS RX's own public disclosures when we last checked them, in September 2026. Prices and terms change without notice — confirm on No BS RX's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.

No BS RX

2 compounds from $179/mo injection, $199 oral

Visit